APA (7th ed.) Citation

JA, J., SY, L., TE, K., JR, K., C, K., W, H., & JW, K. (2015). Lack of the effect of lobeglitazone, a peroxisome proliferator-activated receptor-γ agonist, on the pharmacokinetics and pharmacodynamics of warfarin. Drug Design, Development and Therapy, 2015(default), 737-743.

Chicago Style (17th ed.) Citation

JA, Jung, Lee SY, Kim TE, Kim JR, Kim C, Huh W, and Ko JW. "Lack of the Effect of Lobeglitazone, a Peroxisome Proliferator-activated Receptor-γ Agonist, on the Pharmacokinetics and Pharmacodynamics of Warfarin." Drug Design, Development and Therapy 2015, no. default (2015): 737-743.

MLA (9th ed.) Citation

JA, Jung, et al. "Lack of the Effect of Lobeglitazone, a Peroxisome Proliferator-activated Receptor-γ Agonist, on the Pharmacokinetics and Pharmacodynamics of Warfarin." Drug Design, Development and Therapy, vol. 2015, no. default, 2015, pp. 737-743.